These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15194839)

  • 1. Heterologous immunity and the nonspecific effects of vaccines: a major medical advance?
    Shann F
    Pediatr Infect Dis J; 2004 Jun; 23(6):555-8. PubMed ID: 15194839
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-specific immunological effects of selected routine childhood immunisations: systematic review.
    Kandasamy R; Voysey M; McQuaid F; de Nie K; Ryan R; Orr O; Uhlig U; Sande C; O'Connor D; Pollard AJ
    BMJ; 2016 Oct; 355():i5225. PubMed ID: 27737830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruptions in the supply of routinely recommended childhood vaccines in the United States.
    Santoli JM; Klein JO; Peter G; Orenstein WA
    Pediatr Infect Dis J; 2004 Jun; 23(6):553-4. PubMed ID: 15194838
    [No Abstract]   [Full Text] [Related]  

  • 4. Non-specific effects of childhood vaccines.
    Yung CF
    BMJ; 2016 Oct; 355():i5434. PubMed ID: 27737824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
    Marlow R; Kuriyakose S; Mesaros N; Han HH; Tomlinson R; Faust SN; Snape MD; Pollard AJ; Finn A
    Vaccine; 2018 Apr; 36(17):2300-2306. PubMed ID: 29576304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of antibodies in 4-8 year old Austrian children after vaccination with hexavalent DTaP-HBV-IPV/Hib and MMR vaccines.
    Paulke-Korinek M; Fischmeister G; Grac A; Rendi-Wagner P; Kundi M; Mohsenzadeh-Rabbani A; Moritz K; Fenninger B; Jarisch R; Jasinska J; Holzmann H; Wiedermann U; Kollaritsch H
    Vaccine; 2011 Jul; 29(32):5130-6. PubMed ID: 21624412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study.
    Heijstek MW; van Gageldonk PG; Berbers GA; Wulffraat NM
    Ann Rheum Dis; 2012 Jun; 71(6):948-54. PubMed ID: 22172491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of immune response following immunization with DTP/Td and MMR vaccines in children treated for acute lymphoblastic leukemia.
    Koochakzadeh L; Khosravi MH; Pourakbari B; Hosseinverdi S; Aghamohammadi A; Rezaei N
    Pediatr Hematol Oncol; 2014 Oct; 31(7):656-63. PubMed ID: 25007393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody responses of healthy infants to concurrent administration of a bivalent haemophilus influenzae type b-hepatitis B vaccine with diphtheria-tetanus-pertussis, polio and measles-mumps-rubella vaccines.
    West DJ; Rabalais GP; Watson B; Keyserling HL; Matthews H; Hesley TM
    BioDrugs; 2001; 15(6):413-8. PubMed ID: 11520252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vaccination in children].
    Vandepitte J
    Rev Med Liege; 1997 Mar; 52(3):149-54. PubMed ID: 9213902
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of combined vaccines in children].
    Plebani A
    Ann Ig; 2002; 14(4 Suppl 5):85-91. PubMed ID: 12389297
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomized trials to study the nonspecific effects of vaccines in children in low-income countries.
    Shann F; Nohynek H; Scott JA; Hesseling A; Flanagan KL;
    Pediatr Infect Dis J; 2010 May; 29(5):457-61. PubMed ID: 20431383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measles, mumps, rubella, and varicella combination vaccine: safety and immunogenicity alone and in combination with other vaccines given to children. Measles, Mumps, Rubella, Varicella Vaccine Study Group.
    White CJ; Stinson D; Staehle B; Cho I; Matthews H; Ngai A; Keller P; Eiden J; Kuter B
    Clin Infect Dis; 1997 May; 24(5):925-31. PubMed ID: 9142794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and safety of a combined measles, mumps, rubella and varicella live vaccine (ProQuad ®) administered concomitantly with a booster dose of a hexavalent vaccine in 12-23-month-old infants.
    Deichmann KA; Ferrera G; Tran C; Thomas S; Eymin C; Baudin M
    Vaccine; 2015 May; 33(20):2379-86. PubMed ID: 25765966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of immunity status to routine vaccination in pediatric liver transplant candidates.
    Dehghani SM; Shakiba MA; Ziaeyan M; Imanieh MH; Haghighat M; Sedaghat M; Alborzi A; Malek-Hosseini SA
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():26-31. PubMed ID: 25910330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current immunization practices. 1. Polio, diphtheria, tetanus, pertussis, measles, mumps, rubella, and influenza.
    Gillum JE; Garrison MW; Crossley KB; Rotschafer JC
    Postgrad Med; 1989 Feb; 85(2):183-6, 188-90, 195-8. PubMed ID: 2783777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From the Centers for Disease Control and Prevention. Recommended childhood immunization schedule--United States, July-December 1996.
    JAMA; 1996 Sep; 276(10):775-6. PubMed ID: 8769579
    [No Abstract]   [Full Text] [Related]  

  • 18. [Routine preventive vaccinations].
    Schubiger G; Desgrandchamps D
    Praxis (Bern 1994); 1998 Jan; 87(5):165-7. PubMed ID: 9522635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination vaccines.
    Chokephaibulkit K
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S694-9. PubMed ID: 12403249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B; Wald E; Guerra N; Byers C
    Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.